Form 483

White Plains Hospital Center Blood Bank Form 483, 2009-11-23

FDA issued a Form 483 to White Plains Hospital Center Blood Bank on 2009-11-23 with 8 public-safe observations.

483· Form 483 issued8 observations

White Plains Hospital Center Blood Bank · White Plains, United States · Issued November 23, 2009

Overview

  • 8 public-safe observations are available for this inspection.
  • 8 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

23 Nov 2009
21 CFR 211.192

No written record of investigation

Cited by Leena Thomas

23 Nov 2009
21 CFR 606.65(e)

Following manufacturer's instructions

Cited by Leena Thomas

23 Nov 2009
21 CFR 606.100(b)

Establish, maintain and follow manufacturing SOPs

Cited by Leena Thomas

23 Nov 2009
21 CFR 606.100(c)

Record review prior to release

Cited by Leena Thomas

23 Nov 2009
21 CFR 606.160(a)(1)

Legibility and indelibility

Cited by Leena Thomas

Inspected site

WPWhite Plains Hospital Center Blood BankWhite Plains, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.192Cited across public-safe Form 483 observations1x
21 CFR 606.100(b)Cited across public-safe Form 483 observations1x
21 CFR 606.100(c)Cited across public-safe Form 483 observations1x
21 CFR 606.160(a)(1)Cited across public-safe Form 483 observations1x
21 CFR 606.160(b)Cited across public-safe Form 483 observations1x
21 CFR 606.171(a)Cited across public-safe Form 483 observations1x
21 CFR 606.65(e)Cited across public-safe Form 483 observations1x
21 CFR 820.70(i)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 8 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere